Potential roles of hyaluronic acid in<i>in vivo</i>CAR T cell reprogramming for cancer immunotherapy-Reference-Cited by-同舟云学术

Potential roles of hyaluronic acid inin vivoCAR T cell reprogramming for cancer immunotherapy

Published:2022 Issue:48 Volume:14 Page:17821-17840
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Laomeephol Chavee¹^ORCID,Areecheewakul Sudartip²,Tawinwung Supannikar²³,Suppipat Koramit³⁴,Chunhacha Preedakorn⁵,Neves Nuno M.⁶⁷^ORCID,Luckanagul Jittima Amie¹⁸^ORCID

Affiliation:

1. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand

2. Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand

3. Chulalongkorn University Cancer Immunology Excellence Center, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

4. Chulalongkorn University Stem Cell and Cell Therapy Research Center, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand

5. Department of Biochemistry and Microbiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand

6. 3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark – Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal

7. ICVS/3B's – PT Government Associate Laboratory, Braga, Guimarães, Portugal

8. Center of Excellence in Plant-produced Pharmaceuticals, Chulalongkorn University, Bangkok 10330, Thailand

Abstract

Hyaluronic acid-based nanoparticles can be promising tools for gene delivery in in vivo reprogramming CAR T cells, as well-designed carriers are needed for targeting and transducing circulating T cells.

Funder

Asahi Glass Foundation

Chulalongkorn University

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NR/D2NR05949E

Reference142 articles.

1. C. H.June , Chapter 30 - Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity , in The Vaccine Book , ed. B. R. Bloom and P.-H. Lambert , Academic Press , 2nd edn, 2016 , pp. 581–596

2. X.Wang and M. I.Nishimura , Chapter 18 - Genetically Engineered (T Cell Receptor) T Cells for Adoptive Therapy , in Gene Therapy of Cancer , ed. E. C. Lattime and S. L. Gerson , Academic Press , San Diego , 3rd edn, 2014 , pp. 259–271

3. In Situ Programming of CAR T Cells

4. Engineering and Design of Chimeric Antigen Receptors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy;International Journal of Biological Macromolecules;2024-07

2. Targeted gene delivery through receptors with lipid nanoparticles;Journal of Drug Delivery Science and Technology;2024-03

3. Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications;Pharmaceutics;2023-11-25